- PLN6.19bn
- PLN7.10bn
- PLN1.95bn
- 61
- 21
- 91
- 61
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21 | ||
| PEG Ratio (f) | 1.22 | ||
| EPS Growth (f) | 20.77% | ||
| Dividend Yield (f) | 2.03% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.57 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 19.55 | ||
| Price to Sales | 3.17 | ||
| EV to EBITDA | 14.54 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 24.93% | ||
| Return on Equity | 90.74% | ||
| Operating Margin | 17.36% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | n/a | n/a | n/a | 1,587.98 | 1,950.15 | 2,317 | 2,625.43 | 22.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +84.71 | +17.35 | +22.83 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Diagnostyka SA is a Poland-based company. It operates a network of medical labs. The Company specializes in providing laboratory services from collecting and transporting biological materials, through testing, to providing the results of medical analysis. It specializes in laboratory tests, specialized tests, Molecular biology tests, Autoimmune diagnostics, blood collection. The Company operates a network of 180 laboratories and 1,100 Sampling Labs throughout Poland. It offers a wide range of laboratory analyzes (over 3000 test types), both routine and specialist, available with and without a physician’s referral, such as hematology, diagnostics of infections, allergology, hormonal diagnostics and more.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- September 2nd, 2021
- Public Since
- February 7th, 2025
- No. of Employees
- 6,967
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange- Shares in Issue
- 33,757,100
- Address
- ul. Prof. Michala Zyczkowskiego 16, KRAKOW, 31-864
- Web
- https://www.diag.pl
- Phone
- +48 122950100
- Auditors
- Ernst & Young Audyt Polska Sp z o.o.
Upcoming Events for DIA
Similar to DIA
Centrum Medyczne Enel Med SA
Warsaw Stock Exchange
Constance Care SA
Warsaw Stock Exchange
Eko-Oze SA
Warsaw Stock Exchange
EMC Instytut Medyczny SA
Warsaw Stock Exchange
Telemedycyna Polska SA
Warsaw Stock Exchange
FAQ
As of Today at 11:15 UTC, shares in Diagnostyka SA are trading at PLN183.25. This share price information is delayed by 15 minutes.
Shares in Diagnostyka SA last closed at PLN183.25 and the price had moved by over the past 365 days. In terms of relative price strength the Diagnostyka SA share price has matched the FTSE Global All Cap Index by over the past year.
The overall consensus recommendation for Diagnostyka SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreDiagnostyka SA does not currently pay a dividend.
Diagnostyka SA does not currently pay a dividend.
Diagnostyka SA does not currently pay a dividend.
To buy shares in Diagnostyka SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN183.25, shares in Diagnostyka SA had a market capitalisation of PLN6.19bn.
Here are the trading details for Diagnostyka SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: DIA
Based on an overall assessment of its quality, value and momentum Diagnostyka SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Diagnostyka SA is PLN179.33. That is 2.14% below the last closing price of PLN183.25.
Analysts covering Diagnostyka SA currently have a consensus Earnings Per Share (EPS) forecast of PLN7.70 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diagnostyka SA. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of PLN183.25, shares in Diagnostyka SA were trading +20.6% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Diagnostyka SA PE ratio based on its reported earnings over the past 12 months is 21. The shares last closed at PLN183.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Diagnostyka SA's directors